Skip to main content

Advertisement

SpringerLink
Log in

Choroidal thickness is affected by many factors which may change the effect of ranibizumab: author’s response

  • Letter to the Editor (by invitation)
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nishide T, Hayakawa N, Nakanishi M, Ishii M, Okazaki S, Kimura I, Shibuya E, Mizuki N (2013) Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy. Graefes Arch Clin Exp Ophthalmol 251:2415–2420. doi:10.1007/s00417-013-2419-z

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Alwassia AA, Adhi M, Zhang JY, Regatieri CV, Al-Quthami A, Salem D, Fujimoto JG, Duker JS (2013) Exercise-induced acute changes in systolic blood pressure do not alter choroidal thickness as measured by a portable spectral-domain optical coherence tomography device. Retina 33:160–165. doi:10.1097/IAE.0b013e3182618c22

    Article  PubMed Central  PubMed  Google Scholar 

  3. Wei WB, Xu L, Jonas JB, Shao L, Du KF, Wang S, Chen CX, Xu J, Wang YX, Zhou JQ, You QS (2013) Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology 120:175–180. doi:10.1016/j.ophtha.2012.07.048

    Article  PubMed  Google Scholar 

  4. Wong IY, Wong RL, Zhao P, Lai WW (2013) Choroidal thickness in relation to hypercholesterolemia on enhanced depth imaging optical coherence tomography. Retina 33:423–428. doi:10.1097/IAE.0b013e3182753b5a

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work or part of the work has not been published or presented in a conference/seminar. We have no support in financial or other relationships that might lead to a conflict of interest. The manuscript has been read and approved by all the authors; the requirements for authorship as stated earlier in this document have been met, and each author believes that the manuscript represents honest work.

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa, Japan, 236-0004

    Tadayuki Nishide, Natsuki Hayakawa, Etsuko Shibuya, Yoko Yagi & Nobuhisa Mizuki

Authors
  1. Tadayuki Nishide
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Natsuki Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Etsuko Shibuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoko Yagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuhisa Mizuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadayuki Nishide.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishide, T., Hayakawa, N., Shibuya, E. et al. Choroidal thickness is affected by many factors which may change the effect of ranibizumab: author’s response. Graefes Arch Clin Exp Ophthalmol 252, 849–850 (2014). https://doi.org/10.1007/s00417-014-2597-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2597-3

Keywords

Search

Navigation